A
SCH 58261
adenosine A2A receptor
astrocyte
neurodegeneration
transcriptional deregulation
Journal
Glia
ISSN: 1098-1136
Titre abrégé: Glia
Pays: United States
ID NLM: 8806785
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
06
12
2018
revised:
10
06
2019
accepted:
18
06
2019
pubmed:
23
7
2019
medline:
14
4
2020
entrez:
23
7
2019
Statut:
ppublish
Résumé
Adenosine A
Substances chimiques
Adenosine A2 Receptor Antagonists
0
Receptor, Adenosine A2A
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2329-2342Informations de copyright
© 2019 Wiley Periodicals, Inc.
Références
Albasanz, J. L., Rodriguez, A., Ferrer, I., & Martin, M. (2006). Adenosine A2A receptors are up-regulated in Pick's disease frontal cortex. Brain Pathology, 16(4), 249-255. https://doi.org/10.1111/j.1750-3639.2006.00026.x
Angulo, E., Casado, V., Mallol, J., Canela, E. I., Vinals, F., Ferrer, I., … Franco, R. (2003). A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation. Brain Pathology, 13(4), 440-451. https://doi.org/10.1111/j.1750-3639.2003.tb00475.x
Baron, L., Gombault, A., Fanny, M., Villeret, B., Savigny, F., Guillou, N., … Couillin, I. (2015). The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine. Cell Death & Disease, 6, e1629. https://doi.org/10.1038/cddis.2014.576
Barros-Barbosa, A. R., Ferreirinha, F., Oliveira, A., Mendes, M., Lobo, M. G., Santos, A., … Correia-de-Sa, P. (2016). Adenosine A2A receptor and ecto-5′-nucleotidase/CD73 are upregulated in hippocampal astrocytes of human patients with mesial temporal lobe epilepsy (MTLE). Purinergic Signal, 12(4), 719-734. https://doi.org/10.1007/s11302-016-9535-2
Bhamidipati, C. M., Mehta, G. S., Moehle, C. W., Meher, A. K., Su, G., Vigneshwar, N. G., … Ailawadi, G. (2013). Adenosine 2A receptor modulates inflammation and phenotype in experimental abdominal aortic aneurysms. The FASEB Journal, 27(6), 2122-2131. https://doi.org/10.1096/fj.12-214197
Boia, R., Elvas, F., Madeira, M. H., Aires, I. D., Rodrigues-Neves, A. C., Tralhao, P., … Santiago, A. R. (2017). Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage. Cell Death & Disease, 8(10), e3065. https://doi.org/10.1038/cddis.2017.451
Bridges, R., Lutgen, V., Lobner, D., & Baker, D. A. (2012). Thinking outside the cleft to understand synaptic activity: Contribution of the cystine-glutamate antiporter (system xc-) to normal and pathological glutamatergic signaling. Pharmacological Reviews, 64(3), 780-802. https://doi.org/10.1124/pr.110.003889
Brodie, C., Blumberg, P. M., & Jacobson, K. A. (1998). Activation of the A2A adenosine receptor inhibits nitric oxide production in glial cells. FEBS Letters, 429(2), 139-142. https://doi.org/10.1016/S0014-5793(98)00556-0
Canas, P. M., Porciúncula, L. O., Cunha, G. M. A., Silva, C. G., Machado, N. J., Oliveira, J. M. A., … Cunha, R. A. (2009). Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by β-amyloid peptides via p38 mitogen-activated protein kinase pathway. The Journal of Neuroscience, 29(47), 14741-14751. https://doi.org/10.1523/jneurosci.3728-09.2009
Cervetto, C., Venturini, A., Passalacqua, M., Guidolin, D., Genedani, S., Fuxe, K., … Agnati, L. F. (2017). A2A-D2 receptor-receptor interaction modulates gliotransmitter release from striatal astrocyte processes. Journal of Neurochemistry, 140(2), 268-279. https://doi.org/10.1111/jnc.13885
Chung, W.-S., Clarke, L. E., Wang, G. X., Stafford, B. K., Sher, A., Chakraborty, C., … Barres, B. A. (2013). Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature, 504, 394-400. https://doi.org/10.1038/nature12776
Clark, J., Clore, E. L., Zheng, K., Adame, A., Masliah, E., & Simon, D. K. (2010). Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice. PLoS One, 5(8), e12333. https://doi.org/10.1371/journal.pone.0012333
Clarke, L. E., Liddelow, S. A., Chakraborty, C., Münch, A. E., Heiman, M., & Barres, B. A. (2018). Normal aging induces A1-like astrocyte reactivity. Proceedings of the National Academy of Sciences, 115(8), E1896-E1905. https://doi.org/10.1073/pnas.1800165115
Cristovao-Ferreira, S., Navarro, G., Brugarolas, M., Perez-Capote, K., Vaz, S. H., Fattorini, G., … Sebastiao, A. M. (2013). A1R-A2AR heteromers coupled to Gs and G i/0 proteins modulate GABA transport into astrocytes. Purinergic Signal, 9(3), 433-449. https://doi.org/10.1007/s11302-013-9364-5
Cunha, R. A. (2016). How does adenosine control neuronal dysfunction and neurodegeneration? Journal of Neurochemistry, 139(6), 1019-1055. https://doi.org/10.1111/jnc.13724
Dobin, A., & Gingeras, T. R. (2015). Mapping RNA-seq reads with STAR. Current Protocols in Bioinformatics, 51, 11.14.11-11.14.19. https://doi.org/10.1002/0471250953.bi1114s51
Faivre, E., Coelho, J. E., Zornbach, K., Malik, E., Baqi, Y., Schneider, M., … Blum, D. (2018). Beneficial effect of a selective adenosine A2A receptor antagonist in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Frontiers in Molecular Neuroscience, 11, 235. https://doi.org/10.3389/fnmol.2018.00235
Ferre, S., Bonaventura, J., Zhu, W., Hatcher-Solis, C., Taura, J., Quiroz, C., … Zwilling, D. (2018). Essential control of the function of the Striatopallidal neuron by pre-coupled complexes of adenosine A2A-dopamine D2 receptor Heterotetramers and adenylyl Cyclase. Frontiers in Pharmacology, 9, 243. https://doi.org/10.3389/fphar.2018.00243
Fogal, B., Li, J., Lobner, D., McCullough, L. D., & Hewett, S. J. (2007). System x(c)-activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury. The Journal of Neuroscience, 27(38), 10094-10105. https://doi.org/10.1523/jneurosci.2459-07.2007
Furman, J. L., Sama, D. M., Gant, J. C., Beckett, T. L., Murphy, M. P., Bachstetter, A. D., … Norris, C. M. (2012). Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease. The Journal of Neuroscience, 32(46), 16129-16140. https://doi.org/10.1523/JNEUROSCI.2323-12.2012
Gołembiowska, K., Wardas, J., Noworyta-Sokołowska, K., Kamińska, K., & Górska, A. (2013). Effects of adenosine receptor antagonists on the in vivo LPS-induced inflammation model of Parkinson's disease. Neurotoxicity Research, 24(1), 29-40. https://doi.org/10.1007/s12640-012-9372-1
González-Reyes, R. E., Nava-Mesa, M. O., Vargas-Sánchez, K., Ariza-Salamanca, D., & Mora-Muñoz, L. (2017). Involvement of astrocytes in Alzheimer's disease from a neuroinflammatory and oxidative stress perspective. Frontiers in Molecular Neuroscience, 10, 427-427. https://doi.org/10.3389/fnmol.2017.00427
Gyoneva, S., Shapiro, L., Lazo, C., Garnier-Amblard, E., Smith, Y., Miller, G. W., & Traynelis, S. F. (2014). Adenosine A(2A) receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease. Neurobiology of Disease, 67, 191-202. https://doi.org/10.1016/j.nbd.2014.03.004
Halder, R., Hennion, M., Vidal, R. O., Shomroni, O., Rahman, R. U., Rajput, A., … Bonn, S. (2016). DNA methylation changes in plasticity genes accompany the formation and maintenance of memory. Nature Neuroscience, 19(1), 102-110. https://doi.org/10.1038/nn.4194
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., … Golenbock, D. T. (2013). NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature, 493(7434), 674-678. https://doi.org/10.1038/nature11729
Heneka, M. T., McManus, R. M., & Latz, E. (2018). Inflammasome signalling in brain function and neurodegenerative disease. Nature Reviews Neuroscience, 19(10), 610-621. https://doi.org/10.1038/s41583-018-0055-7
Hu, Q., Ren, X., Liu, Y., Li, Z., Zhang, L., Chen, X., … Chen, J. F. (2016). Aberrant adenosine A2A receptor signaling contributes to neurodegeneration and cognitive impairments in a mouse model of synucleinopathy. Experimental Neurology, 283(Pt A), 213-223. https://doi.org/10.1016/j.expneurol.2016.05.040
Jackman, N. A., Uliasz, T. F., Hewett, J. A., & Hewett, S. J. (2010). Regulation of system x(c) (-)activity and expression in astrocytes by interleukin-1beta: Implications for hypoxic neuronal injury. Glia, 58(15), 1806-1815. https://doi.org/10.1002/glia.21050
Kamphuis, W., Kooijman, L., Orre, M., Stassen, O., Pekny, M., & Hol, E. M. (2015). GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease. Glia, 63(6), 1036-1056. https://doi.org/10.1002/glia.22800
Ke, R. H., Xiong, J., Liu, Y., & Ye, Z. R. (2009). Adenosine A2a receptor induced gliosis via Akt/NF-kappaB pathway in vitro. Neuroscience Research, 65(3), 280-285. https://doi.org/10.1016/j.neures.2009.08.002
Kim, D. G., & Bynoe, M. S. (2015). A2A adenosine receptor regulates the human blood-brain barrier permeability. Molecular Neurobiology, 52(1), 664-678. https://doi.org/10.1007/s12035-014-8879-2
Kitazawa, M., Cheng, D., Tsukamoto, M. R., Koike, M. A., Wes, P. D., Vasilevko, V., … LaFerla, F. M. (2011). Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal beta-catenin pathway function in an Alzheimer's disease model. Journal of Immunology, 187(12), 6539-6549. https://doi.org/10.4049/jimmunol.1100620
Laurent, C., Burnouf, S., Ferry, B., Batalha, V. L., Coelho, J. E., Baqi, Y., … Blum, D. (2016). A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. Molecular Psychiatry, 21, 97-107. https://doi.org/10.1038/mp.2014.151
Laurent, C., Eddarkaoui, S., Derisbourg, M., Leboucher, A., Demeyer, D., Carrier, S., … Blum, D. (2014). Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology. Neurobiology of Aging, 35(9), 2079-2090. https://doi.org/10.1016/j.neurobiolaging.2014.03.027
Lee, C. C., Chang, C. P., Lin, C. J., Lai, H. L., Kao, Y. H., Cheng, S. J., … Chern, Y. (2018). Adenosine augmentation evoked by an ENT1 inhibitor improves memory impairment and neuronal plasticity in the APP/PS1 mouse model of Alzheimer's disease. Molecular Neurobiology, 55(12), 8936-8952. https://doi.org/10.1007/s12035-018-1030-z
Lewerenz, J., Hewett, S. J., Huang, Y., Lambros, M., Gout, P. W., Kalivas, P. W., … Maher, P. (2013). The cystine/glutamate antiporter system x(c)(-) in health and disease: From molecular mechanisms to novel therapeutic opportunities. Antioxidants & Redox Signaling, 18(5), 522-555. https://doi.org/10.1089/ars.2011.4391
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., … Barres, B. A. (2017). Neurotoxic reactive astrocytes are induced by activated microglia. Nature, 541(7638), 481-487. https://doi.org/10.1038/nature21029
Lopes, L. V., Cunha, R. A., Kull, B., Fredholm, B. B., & Ribeiro, J. A. (2002). Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition. Neuroscience, 112(2), 319-329. https://doi.org/10.1016/S0306-4522(02)00080-5
Love, M. I., Huber, W., & Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology, 15(12), 550. https://doi.org/10.1186/s13059-014-0550-8
Massie, A., Schallier, A., Kim, S. W., Fernando, R., Kobayashi, S., Beck, H., … Michotte, Y. (2011). Dopaminergic neurons of system x(c)(-)-deficient mice are highly protected against 6-hydroxydopamine-induced toxicity. The FASEB Journal, 25(4), 1359-1369. https://doi.org/10.1096/fj.10-177212
Mathys, H., Davila-Velderrain, J., Peng, Z., Gao, F., Mohammadi, S., Young, J. Z., … Tsai, L. H. (2019). Single-cell transcriptomic analysis of Alzheimer's disease. Nature, 570, 332-337. https://doi.org/10.1038/s41586-019-1195-2
Matos, M., Augusto, E., Santos-Rodrigues, A. D., Schwarzschild, M. A., Chen, J. F., Cunha, R. A., & Agostinho, P. (2012). Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes. Glia, 60(5), 702-716. https://doi.org/10.1002/glia.22290
Matos, M., Augusto, E., Agostinho, P., Cunha, R. A., & Chen, J. F. (2013). Antagonistic interaction between adenosine A2A receptors and Na+/K+-ATPase-alpha2 controlling glutamate uptake in astrocytes. The Journal of Neuroscience, 33(47), 18492-18502. https://doi.org/10.1523/jneurosci.1828-13.2013
Matos, M., Shen, H. Y., Augusto, E., Wang, Y., Wei, C. J., Wang, Y. T., … Chen, J. F. (2015). Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: Relevance to schizophrenia. Biological Psychiatry, 78(11), 763-774. https://doi.org/10.1016/j.biopsych.2015.02.026
Minghetti, L., Greco, A., Potenza, R. L., Pezzola, A., Blum, D., Bantubungi, K., & Popoli, P. (2007). Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration. Journal of Neuropathology and Experimental Neurology, 66(5), 363-371. https://doi.org/10.1097/nen.0b013e3180517477
Naudé, P. J. W., Nyakas, C., Eiden, L. E., Ait-Ali, D., van der Heide, R., Engelborghs, S., … Eisel, U. L. M. (2012). Lipocalin 2: Novel component of proinflammatory signaling in Alzheimer's disease. The FASEB Journal, 26(7), 2811-2823. https://doi.org/10.1096/fj.11-202457
Nicolia, V., Cavallaro, R. A., Lopez-Gonzalez, I., Maccarrone, M., Scarpa, S., Ferrer, I., & Fuso, A. (2017). DNA methylation profiles of selected pro-inflammatory cytokines in Alzheimer disease. Journal of Neuropathology and Experimental Neurology, 76(1), 27-31. https://doi.org/10.1093/jnen/nlw099
Nobre, H. V., Jr., Cunha, G. M., de Vasconcelos, L. M., Magalhaes, H. I., Oliveira Neto, R. N., Maia, F. D., … Viana, G. S. (2010). Caffeine and CSC, adenosine A2A antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells. Neurochemistry International, 56(1), 51-58. https://doi.org/10.1016/j.neuint.2009.09.001
Ogawa, Y., Furusawa, E., Saitoh, T., Sugimoto, H., Omori, T., Shimizu, S., … Oishi, K. (2018). Inhibition of astrocytic adenosine receptor A2A attenuates microglial activation in a mouse model of Sandhoff disease. Neurobiology of Disease, 118, 142-154. https://doi.org/10.1016/j.nbd.2018.07.014
Orr, A. G., Orr, A. L., Li, X. J., Gross, R. E., & Traynelis, S. F. (2009). Adenosine A(2A) receptor mediates microglial process retraction. Nature Neuroscience, 12(7), 872-878. https://doi.org/10.1038/nn.2341
Orr, A. G., Hsiao, E. C., Wang, M. M., Ho, K., Kim, D. H., Wang, X., … Mucke, L. (2015). Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory. Nature Neuroscience, 18(3), 423-434. https://doi.org/10.1038/nn.3930
Orr, A. G., Lo, I., Schumacher, H., Ho, K., Gill, M., Guo, W., … Mucke, L. (2018). Istradefylline reduces memory deficits in aging mice with amyloid pathology. Neurobiology of Disease, 110, 29-36. https://doi.org/10.1016/j.nbd.2017.10.014
Osborn, L. M., Kamphuis, W., Wadman, W. J., & Hol, E. M. (2016). Astrogliosis: An integral player in the pathogenesis of Alzheimer's disease. Progress in Neurobiology, 144, 121-141. https://doi.org/10.1016/j.pneurobio.2016.01.001
Ouyang, X., Ghani, A., Malik, A., Wilder, T., Colegio, O. R., Flavell, R. A., … Mehal, W. Z. (2013). Adenosine is required for sustained inflammasome activation via the A₂A receptor and the HIF-1α pathway. Nature Communications, 4, 2909-2909. https://doi.org/10.1038/ncomms3909
Paco, S., Pozas, E., & Aguado, F. (2010). Secretogranin III is an astrocyte Granin that is overexpressed in reactive glia. Cerebral Cortex, 20(6), 1386-1397. https://doi.org/10.1093/cercor/bhp202
Pekny, M., Pekna, M., Messing, A., Steinhauser, C., Lee, J. M., Parpura, V., … Verkhratsky, A. (2016). Astrocytes: A central element in neurological diseases. Acta Neuropathologica, 131(3), 323-345. https://doi.org/10.1007/s00401-015-1513-1
Pelassa, S., Guidolin, D., Venturini, A., Averna, M., Frumento, G., Campanini, L., … Marcoli, M. (2019). A2A-D2 heteromers on striatal astrocytes: Biochemical and biophysical evidence. International Journal of Molecular Sciences, 20(10), 2457. https://doi.org/10.3390/ijms20102457
Querol-Vilaseca, M., Colom-Cadena, M., Pegueroles, J., San Martín-Paniello, C., Clarimon, J., Belbin, O., … Lleó, A. (2017). YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer's disease and other tauopathies. Journal of Neuroinflammation, 14(1), 118-118. https://doi.org/10.1186/s12974-017-0893-7
Rebola, N., Lujan, R., Cunha, R. A., & Mulle, C. (2008). Adenosine A2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses. Neuron, 57(1), 121-134. https://doi.org/10.1016/j.neuron.2007.11.023
Rebola, N., Simoes, A. P., Canas, P. M., Tome, A. R., Andrade, G. M., Barry, C. E., … Cunha, R. A. (2011). Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction. Journal of Neurochemistry, 117(1), 100-111. https://doi.org/10.1111/j.1471-4159.2011.07178.x
Saura, C. A., Parra-Damas, A., & Enriquez-Barreto, L. (2015). Gene expression parallels synaptic excitability and plasticity changes in Alzheimer's disease. Frontiers in Cellular Neuroscience, 9, 318. https://doi.org/10.3389/fncel.2015.00318
Shaftel, S. S., Griffin, W. S. T., & O'Banion, M. K. (2008). The role of interleukin-1 in neuroinflammation and Alzheimer disease: An evolving perspective. Journal of Neuroinflammation, 5, 7. https://doi.org/10.1186/1742-2094-5-7
Sheng, J. G., Zhu, S. G., Jones, R. A., Griffin, W. S., & Mrak, R. E. (2000). Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Experimental Neurology, 163(2), 388-391. https://doi.org/10.1006/exnr.2000.7393
Shi, Y., Yamada, K., Liddelow, S. A., Smith, S. T., Zhao, L., Luo, W., … Holtzman, D. M. (2017). ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature, 549(7673), 523-527. https://doi.org/10.1038/nature24016
Silva, A. C., Lemos, C., Goncalves, F. Q., Pliassova, A. V., Machado, N. J., Silva, H. B., … Agostinho, P. (2018). Blockade of adenosine A2A receptors recovers early deficits of memory and plasticity in the triple transgenic mouse model of Alzheimer's disease. Neurobiology of Disease, 117, 72-81. https://doi.org/10.1016/j.nbd.2018.05.024
Sofroniew, M. V., & Vinters, H. V. (2010). Astrocytes: Biology and pathology. Acta Neuropathologica, 119(1), 7-35. https://doi.org/10.1007/s00401-009-0619-8
Spellman, D. S., Wildsmith, K. R., Honigberg, L. A., Tuefferd, M., Baker, D., Raghavan, N., … Potter, W. Z. (2015). Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's disease neuroimaging initiative (ADNI) CSF. Proteomics Clinical Applications, 9(7-8), 715-731. https://doi.org/10.1002/prca.201400178
Temido-Ferreira, M., Ferreira, D. G., Batalha, V. L., Marques-Morgado, I., Coelho, J. E., Pereira, P., … Lopes, L. V. (2018). Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors. Molecular Psychiatry. 23, 1-25 https://doi.org/10.1038/s41380-018-0110-9
Venegas, C., Kumar, S., Franklin, B. S., Dierkes, T., Brinkschulte, R., Tejera, D., … Heneka, M. T. (2017). Microglia-derived ASC specks cross-seed amyloid-beta in Alzheimer's disease. Nature, 552(7685), 355-361. https://doi.org/10.1038/nature25158
Verkhratsky, A., Olabarria, M., Noristani, H. N., Yeh, C.-Y., & Rodriguez, J. J. (2010). Astrocytes in Alzheimer's disease. Neurotherapeutics, 7(4), 399-412. https://doi.org/10.1016/j.nurt.2010.05.017
Verkhratsky, A., & Nedergaard, M. (2018). Physiology of astroglia. Physiological Reviews, 98(1), 239-389. https://doi.org/10.1152/physrev.00042.2016
Viana da Silva, S., Haberl, M. G., Zhang, P., Bethge, P., Lemos, C., Goncalves, N., … Mulle, C. (2016). Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A2A receptors. Nature Communications, 7, 11915. https://doi.org/10.1038/ncomms11915
Villar-Menendez, I., Porta, S., Buira, S. P., Pereira-Veiga, T., Diaz-Sanchez, S., Albasanz, J. L., … Barrachina, M. (2014). Increased striatal adenosine A2A receptor levels is an early event in Parkinson's disease-related pathology and it is potentially regulated by miR-34b. Neurobiology of Disease, 69, 206-214. https://doi.org/10.1016/j.nbd.2014.05.030
Yu, L., Shen, H. Y., Coelho, J. E., Araujo, I. M., Huang, Q. Y., Day, Y. J., … Chen, J. F. (2008). Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms. Annals of Neurology, 63(3), 338-346. https://doi.org/10.1002/ana.21313
Zamanian, J. L., Xu, L., Foo, L. C., Nouri, N., Zhou, L., Giffard, R. G., & Barres, B. A. (2012). Genomic analysis of reactive astrogliosis. The Journal of Neuroscience, 32(18), 6391-6410. https://doi.org/10.1523/jneurosci.6221-11.2012
Zhao, Z. A., Li, P., Ye, S. Y., Ning, Y. L., Wang, H., Peng, Y., … Zhou, Y. G. (2017). Perivascular AQP4 dysregulation in the hippocampal CA1 area after traumatic brain injury is alleviated by adenosine A2A receptor inactivation. Scientific Reports, 7(1), 2254. https://doi.org/10.1038/s41598-017-02505-6